EU Drugs Regulator Reviews Safety of GlaxoSmithKline’s Flu Jab, Probes Swine Flu Shot, Narcolepsy Link

August 27, 2010 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

LONDON (Reuters) - Europe's drug regulator is reviewing the safety of GlaxoSmithKline's Pandemrix flu vaccine, which has been given to more than 30 million people in Europe, to investigate possible links to a sleep disorder.

Twitter
LinkedIn
Facebook
Email
Print

Europe

GSK